Maternal and Postnatal Outcomes: A worldwide decentralized observational registry to evaluate the safety in women with Fabry disease and their infants after exposure to Elfabrio (pegunigalsidase alfa-iwxj/pegunigalsidase alfa) during pregnancy and/or lactation